Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:1894-1900

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sparks, P. B.
Right arrow Articles by Kalman, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sparks, P. B.
Right arrow Articles by Kalman, J. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation
*Pacemakers and Implantable Defibrillators
Related Collections
Right arrow Remodeling
Right arrow Pacemaker
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 1999;100:1894-1900.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Electrical Remodeling of the Atria Following Loss of Atrioventricular Synchrony

A Long-Term Study in Humans

Presented in part and received first prize at The NASPE Young Investigators' Clinical Research Competition at the 19th Annual Scientific Sessions, San Diego, California, May 1998; presented in part at the 46th Annual Scientific Sessions of the Cardiac Society of Australia and New Zealand, Perth, Australial, August 1998; and won the Ralph Reader Prize for Clinical Research at these Sessions.

Paul B. Sparks, MBBS, PhD; Harry G. Mond, MD; Jitendra K. Vohra, MD; Shenthar Jayaprakash, MD; Jonathan M. Kalman, MBBS, PhD

From The Department of Cardiology, The Royal Melbourne Hospital (P.B.S., H.G.M., J.K.V., S.J., J.M.K.), and The Department of Medicine, University of Melbourne (P.B.S., J.M.K.), Melbourne, Australia.

Correspondence to Dr Jonathan M. Kalman, Department of Cardiology, The Royal Melbourne Hospital, Victoria, 3050, Australia. E-mail jon.kalman{at}nwhcn.org.au


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Evidence suggests that an increased incidence of atrial fibrillation occurs in patients undergoing single-chamber ventricular pacing (VVI) when compared with those undergoing single-chamber atrial pacing (AAI) or those having dual-chamber atrioventricular pacing (DDD). The mechanism for this is unknown. We hypothesized that long-term loss of atrioventricular (AV) synchrony leads to atrial electrical remodeling: a potential explanation for this difference.

Methods and Results—The study was a prospective, randomized comparison between 18 patients paced in VVI mode and 12 patients paced in DDD mode for 3 months. Under autonomic blockade, effective refractory periods (ERPs) from the lateral right atrium (RA), RA appendage, RA septum, and coronary sinus–corrected sinus node recovery times (cSNRTs), as well as P-wave duration (PWD), and biatrial diameters were measured at baseline and 3 months. The VVI group was then programmed to DDD pacing and reevaluated after a further 3 months. After long-term VVI pacing, ERPs at all 4 atrial sites increased significantly in a nonuniform fashion in association with biatrial dilatation. PWD and cSNRTs also prolonged significantly. With the reestablishment of AV synchrony, ERPs, PWD, cSNRTs, and biatrial dimensions returned to baseline levels. In the 12 patients who underwent long-term DDD pacing from baseline, no significant changes in atrial electrophysiology or biatrial dimensions were demonstrated.

Conclusions—Long-term loss of AV synchrony induced by VVI pacing is associated with atrial electrical remodeling, which is reversible after the reestablishment of AV synchrony with DDD pacing. This process may be partly responsible for the higher incidence of atrial fibrillation in patients undergoing VVI pacing compared with AV sequential pacing.


Key Words: atrium • electrophysiology • fibrillation • pacemakers • remodeling


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Electrical remodeling of the atrium has been clearly demonstrated in animal models and in humans.1 2 3 4 In studies of electrical remodeling, it has been shown that atrial fibrillation (AF) begets AF due to a fall in atrial effective refractory periods (ERPs), suggesting that this is a major mechanism for the development of the chronic form of the arrhythmia.1 2 4

However, not all investigators have observed a decrease in atrial ERPs in other situations associated with AF. Some authors have observed that the remodeling process is considerably more complex than a simple relationship to a fall in refractoriness.5 6 7 Experimental observations in a canine model suggest that increases in atrial size and pressure cause an increase in atrial refractoriness and dispersion of ERPs, which slow conduction velocity and increase AF inducibility.5 6 Conversely, in isolated rabbit atria, Ravelli and Allessie8 observed a fall in atrial ERPs with short-term atrial stretch. Human data have, thus far, been limited to short-term pacing studies; here, too, conflicting data exist.9 10

An emerging body of evidence suggests that long-term asynchronous ventricular pacing (VVI) is associated with an increased incidence of AF; ongoing multicenter trials are addressing this issue.11 12 13 14 The mechanism underlying this observation is unknown. We hypothesized that the long-term loss of atrioventricular (AV) synchrony associated with VVI pacing leads to atrial electrical remodeling as a potential explanation for this difference. Serial electrophysiological studies were used to prospectively evaluate the effects of a long-term loss in AV synchrony on atrial refractoriness, atrial conduction, and sinus node function in patients with dual-chamber pacemakers implanted for AV block or sinus bradycardia.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Study Patients
The study population consisted of 30 patients with AV block or sinus bradycardia who required permanent, dual-chamber pacing. The underlying atrial rhythm of all patients was sinus before study entry. No patient had paroxysmal or long-term AF. All patients gave written, informed consent to the study, which was approved by the Board of Medical Research of The Royal Melbourne Hospital. The study methodology is summarized in Figure 1Down.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 1. Study design. TTE indicates transthoracic echocardiography.

All patients underwent implantation of bipolar atrial and ventricular leads connected to a dual-chamber pacemaker. The atrial lead was positioned in the right atrial (RA) appendage, and the ventricular lead was placed at the right ventricular apex. Multiprogrammable pacemakers with extended memory and the capability for noninvasive, programmed stimulation were implanted, which permitted the retrieval of sensing and pacing frequencies during interval periods. Patients underwent DDD pacing at 75 beats/min, with an AV delay of 180 ms, for 2 weeks. Then, they presented for a baseline electrophysiologic study (EPS) and assessment of left atrial and RA dimensions.

Echocardiographic Analysis
Patients underwent transthoracic echocardiography with commercially available 2.25- to 3.5-MHz transducers connected to a Hewlett-Packard Sonos-2500 ultrasound system. Dimensions for echocardiography were acquired during sequential pacing at 75 beats/min with an AV interval of 180 ms. Atrial dimensions were determined with the apical 4-chamber view at end systole from a fiducial intercostal space to standardize imaging between studies. Superior-inferior dimensions (atrial length from the mitral or tricuspid annulus to the posterior edge of the chamber) and medial-lateral dimensions (midcavity diameter) were recorded.15

Electrophysiological Function
Three intracardiac quadripolar electrodes with an interelectrode spacing of 2, 5, and 2 mm were inserted via the right femoral vein and positioned in the distal coronary sinus (DCS), lateral RA free wall, and midatrial septum under fluoroscopic guidance. Then, autonomic blockade with atropine (0.04 mg/kg) and propranolol (0.2 mg/kg) was administered intravenously over 10 minutes.16 The mean dose of atropine was 2.4±0.5 mg, and the mean dose of propranolol was 10.0±3.2 mg. The pacemaker was then temporarily reprogrammed to VVI pacing at 30 beats/min to allow the underlying atrial rhythm to become manifest and to facilitate the evaluation of ERPs, sinus node function, and P-wave duration (PWD).

Fifteen minutes after autonomic blockade, ERPs were evaluated at twice diastolic threshold (for a pacing threshold of <2 mA) at cycle lengths of 600 and 450 ms. An incremental technique was used, starting with an S2 coupling interval of 170 ms, which was increased in increments of 5 ms. The ERP was defined as the longest coupling interval failing to propagate to the atrium. ERPs were measured from the lateral RA, midinteratrial septum, and DCS 3 times during each cycle length. If the maximum and minimum measurements differed by >10 ms, 2 more measurements were taken, and the total was averaged. Right and left anterior oblique digital images were archived to help standardize catheter locations for subsequent studies. The noninvasive, programmed stimulation function of the pacemaker was invoked to evaluate ERPs from the electrode implanted in the RA appendage, as described above.

To estimate intrastudy variability, the lateral RA ERPs at 600 and 450 ms were determined twice in 10 patients at baseline. After initial ERP determinations, the catheter was withdrawn into the inferior vena cava and then repositioned where the initial ERP was assessed. Intrastudy variability was 3.04% at 600 ms and 4.22% at 450 ms.

Atrial dispersion of refractoriness was calculated by subtracting the minimum ERP from the maximum ERP determined at the lateral RA, RA appendage, midinteratrial septum, and DCS sites.1 5 6 To determine whether changes in ERPs were uniform, the percentage change at each site was compared.

The corrected sinus node recovery time (cSNRT) was assessed at cycle lengths of 600 and 450 ms after a 30-s pacing train.6 Pacing was performed from the high lateral RA, repeated 3 times, and averaged. Patients with abnormally prolonged cSNRTs at baseline (>1500 ms) were excluded from analysis.

The unpaced PWD in sinus rhythm was analyzed as a marker of interatrial conduction time; it was measured from lead II of the surface ECG and averaged from a series of 20 consecutive, unpaced P-waves separate from the QRS complex.6 Measurements were performed using electronic callipers.

The presence of ventriculoatrial conduction was defined as a 1:1 ventriculoatrial relationship during pacing from the permanent ventricular lead at a rate of 75 beats/min followed by an atrial electrogram on the temporary lateral RA electrode for a 15-s period.

Long-Term Pacing
Randomization to long-term pacing was then done using a 3:2 VVI:DDD design (Figure 1Up). This ratio was determined a priori, because considerable drop-out in the VVI group was anticipated due to intolerance to the loss of AV synchrony. At baseline, 18 patients were programmed to VVI at 75/min, and 12 patients were programmed to DDD at 75/min, with an AV delay of 180 ms.

Three-Month Follow-Up
Patients returned after 3 months for transthoracic echocardiography and EPS, as described in detail above. Patients originally randomized to VVI pacing were then reprogrammed to DDD. These patients were followed for a subsequent 3-month period and reevaluated at 6 months. The patients originally randomized to DDD pacing remained in the DDD mode and were not studied further.

Six-Month Follow-Up
Patients who had been reprogrammed to DDD pacing (from VVI) at 3 months returned for a third echocardiographic and electrophysiological evaluation.

Statistical Analysis
Variables are reported as mean±SD. A repeated measures ANOVA was used to compare continuous variables. Scheffe's F test was used for multiple comparisons. Intrastudy ERP variability was calculated using the following formula17 : {Sigma}[observation 1-observation 2/observation 1]/total observations. Differences between categoric variables were evaluated with 2x2 contingency tables using the {chi}2 test. Statistical significance was established at P<0.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Patient Characteristics
No significant differences in clinical variables were present after randomization to VVI and DDD pacing (Table 1Down). Two patients from the VVI group were excluded before the second EPS due to antiarrhythmic treatment initiated after the development of AF. One 85-year-old man in the group randomized to VVI pacing died suddenly 2 months after the second EPS during the DDD phase of the study.


View this table:
[in this window]
[in a new window]
 
Table 1. Baseline Characteristics of Patients

Pacemaker Telemetry
All patients randomized to VVI for the initial 3-month period demonstrated 100% ventricular pacing. At 6 months, after reprogramming to the DDD mode, atrial sensing/atrial pacing with 100% ventricular pacing was demonstrated in all patients. Ten of the 12 patients (83%) randomized to DDD pacing for the initial 3 months demonstrated atrial sensing/atrial pacing with 100% ventricular pacing; the remaining 2 patients in this group demonstrated atrial sensing/atrial pacing with 75% to 90% ventricular pacing.

Atrial Dimensions
After DDD pacing for 3 months, left atrial and RA dimensions did not change significantly from baseline (Table 2Down). After VVI pacing for 3 months, left atrial superior-inferior dimensions increased from 4.7±0.4 to 5.1±0.2 cm (P<0.01), and medial-lateral dimensions increased from 4.1±0.5 to 4.6±0.5 cm (P<0.05). RA dilatation also developed, with superior-inferior dimensions increasing from 4.3±0.3 to 5.3±0.7 cm (P<0.01) and medial-lateral dimensions increasing from 3.9±0.3 to 4.5±0.3 cm (P<0.01). At 6 months, after reprogramming to DDD pacing, atrial dimensions returned to values comparable to baseline.


View this table:
[in this window]
[in a new window]
 
Table 2. Atrial Dimensions in the VVI/DDD Crossover Group and the DDD Group

Atrial ERPs and Rate Adaptation
After long-term VVI pacing, lateral RA, RA appendage, septal, and DCS ERPs increased significantly at both 600 and 450 ms drive cycle lengths (Table 3Down and Figures 2Down and 3Down). The proportional increase in ERPs at all sites was more marked at a cycle length of 600 ms than one of 450 ms (Figure 4Down). After programming to DDD and reassessment after 3 months, ERPs at all 4 sites and at both cycle lengths returned to values comparable to baseline. At baseline, 3 months, and 6 months, a consistent increase in atrial refractoriness was demonstrated, with increasing cycle lengths, suggesting the presence of ERP adaptation to rate.


View this table:
[in this window]
[in a new window]
 
Table 3. ERPs at Baseline and After VVI or DDD Pacing



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Effects of long-term pacing on atrial ERPs at drive cycle length of 600 ms. Left, Atrial ERPs at baseline and after long-term VVI pacing for 3 months followed by long-term DDD pacing and assessment at 6 months. Right, Atrial ERPs at baseline and after long-term DDD pacing for 3 months. Arrows indicate pacing mode in the interval 3-month period; {triangleup}, lateral RA; {blacktriangleup}, RA appendage; {square}, atrial septum; and {blacksquare}, coronary sinus. Standard error bars are indicated.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Effects of long-term pacing on atrial ERPs at drive cycle length of 450 ms. Left, Atrial ERPs at baseline and after long-term VVI pacing for 3 months followed by long-term DDD pacing and assessment at 6 months. Right, Atrial ERPs at baseline and after long-term DDD pacing for 3 months. Symbols as in Figure 2Up. Standard error bars are indicated.



View larger version (10K):
[in this window]
[in a new window]
 
Figure 4. Effects of long-term VVI pacing on percentage increase in ERP from baseline at 4 atrial sites at drive cycle lengths of 600 and 450 ms. CS indicates coronary sinus; LRA, lateral right atrium; RAA, right atrial appendage; and RAS, right atrial septum.

The group randomized to DDD pacing displayed no significant differences in atrial ERPs from baseline at cycle lengths of 600 and 450 ms at any site. ERPs increased with increasing rate at the 4 atrial sites, also suggesting the presence of ERP adaptation to rate.

ERP Dispersion
Increases in refractoriness occurred in a nonuniform fashion. Absolute and relative increases in ERP were more marked at the lateral RA and septum compared with the RA appendage and DCS (P<0.05). Relative increases were 18.5%, 19.6%, 10.7%, and 8.6%, respectively, at 600 ms and 13.9%, 15.7%, 8.2%, and 5.5%, respectively, at 450 ms (Figure 4Up). After reprogramming to DDD, relative decreases after a further 3 months of pacing were 15.8%, 19.4%, 9.8%, and 8.1%, respectively, at 600 ms and 15.6%, 13.1%, 9.5%, and 6.5%, respectively, at 450 ms. Relative decreases in refractoriness were more pronounced in the lateral RA and septum compared with the DCS and RA appendage.

Baseline ERP dispersion was similar between the DDD and VVI groups at 600 ms (59±21 versus 42±25 ms; P=0.13) and 450 ms (60±30 versus 49±22 ms; P=0.37). Although the increases in refractoriness after 3 months of VVI pacing were nonuniform, the dispersion of refractoriness as prospectively defined did not change significantly. ERP dispersion after DDD pacing for a further 3 months demonstrated a nonsignificant decrease at 600 and 450 ms (Table 3Up). In the group assigned to DDD pacing from baseline, ERP dispersion after DDD pacing for 3 months decreased significantly at both 600 and 450 ms.

Sinus Node Function
Two patients were excluded from analysis because of cSNRTs >1500 ms at baseline. After long-term VVI pacing, cSNRTs increased significantly at drive cycle lengths of 450 ms (271±257 versus 573±311 ms; P<0.01) and 600 ms (321±258 versus 442±244 ms; P=0.02). At 6 months, after reestablishment of AV synchrony with DDD pacing, cSNRT decreased to 346±329 ms at 450 ms (P=0.12 versus baseline) and to 276±119 ms at 600 ms (P=0.10 versus baseline). DDD pacing for 3 months was not associated with significant changes in cSNRTs at drive cycle lengths of 450 ms (391±270 versus 478±323 ms; P=0.39) or 600 ms (401±341 versus 404±335 ms; P=0.92).

PWD
PWD increased significantly after VVI pacing for 3 months (92±8 versus 116±20 ms; P=0.017). After reprogramming to DDD pacing for an additional 3-month period, PWD returned to values comparable to baseline (100±4 ms; P=0.10). DDD pacing for 3 months was not associated with significant changes in PWD compared with baseline values (104±10 versus 106±11 ms; P=0.37).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
This serial electrophysiological study of pacemaker recipients presents new information regarding electrophysiological remodeling of the atrium in humans after the long-term loss of normal AV synchrony. To our knowledge, this is the first prospective evaluation of long-term changes in atrial electrophysiology in humans.

Long-term VVI pacing was associated with biatrial dilatation and significant changes in atrial electrophysiology. After VVI pacing for 3 months, a significant and nonuniform increase in ERPs occurred in the RA free wall, midinteratrial septum, RA appendage, and DCS at drive cycle lengths of 600 and 450 ms. Accompanying these changes was an increase in PWD, suggesting the development of slowed conduction. Long-term VVI pacing was also associated with a significant increase in cSNRT. These changes were not observed in patients paced in the DDD mode in whom AV synchrony was preserved.

The electrophysiological phenomena occurring as a consequence of long-term VVI pacing were reversible. After the reestablishment of AV synchrony with DDD pacing for 3 months, all parameters returned to values comparable to baseline.

Asynchronous Pacing and the Development of AF
Long-term asynchronous ventricular pacing is associated with an increased incidence of AF compared with atrial pacing. Observational studies demonstrate a {approx}2- to 3-fold increase in the incidence of AF for ventricular pacing compared with atrial pacing, and evidence from several prospective, randomized trials have supported these findings.11 12 13 14 However, the mechanism by which asynchronous ventricular pacing leads to this increased incidence of AF is unknown.

Electrical Remodeling With Rapid Atrial Rates
The concept of atrial electrical remodeling was initially described in animal models in which rapid atrial pacing or induced AF produced changes in atrial electrophysiological properties that supported the initiation and perpetuation of AF. These changes included a shortening of atrial refractoriness, loss of rate-dependent shortening of ERP with increasing rate, increased dispersion of refractoriness, prolongation of intra-atrial conduction, and sinus node dysfunction.1 2 3 6 Electrical remodeling has also been demonstrated in humans, in whom several minutes of AF is sufficient to induce atrial ERP abbreviation for <=8 minutes, with heightened susceptibility to AF.4 However, not all investigators have observed a decrease in atrial ERPs in other situations known to be associated with AF, suggesting that the development of AF is a complex and heterogenous process.5 7 18 19 20 21 22

Electrical Remodeling Associated With Atrial Dilatation
Long-term right ventricular pacing in ovine models is associated with progressive atrial dilatation and increased atrial ERPs, with a heightened susceptibility to AF.20 21 In addition, long-term atrial enlargement in patients with AF has been associated with prolongation of right atrial ERPs and less dispersion of atrial refractoriness than controls.22 23 However, long-term atrial dilatation in canine models of mitral valve fibrosis and tricuspid valve avulsion/pulmonary artery banding has been associated with susceptibility to atrial arrhythmias, without changes in transmembrane potentials.24 25

The effects of short-term stretch on atrial electrophysiology have also been investigated. Atrial dilatation caused by volume loading and AV interval manipulation in dogs is associated with heterogenous increases in atrial ERPs, interatrial conduction delays, and a propensity to AF.5 18 19 A nonsignificant prolongation of atrial refractoriness has also been demonstrated after short-term volume loading in goats.26 In contrast, short-term increases in atrial pressure in an isolated rabbit model resulted in susceptibility to AF and shortening of atrial ERPs.8

A paucity of human studies exist that evaluate the effects of short-term atrial stretch on electrophysiological parameters; here, too, conflicting data exist. Increasing RA pressure with volume loading is associated with both an increase in atrial refractoriness and AF inducibility.27 However, atrial pressure elevation caused by AV interval manipulation has been associated with either an increase or no change in atrial ERPs.9 10

Our findings of nonuniform prolongation of atrial ERPs, increased PWD, and impairment of sinus node function after long-term loss of AV synchrony are consistent with those from prior human studies of short-term atrial dilatation and animal studies of long-term atrial dilatation.5 9 18 20 21 Persistence of ERP adaptation to rate contrasts with animal studies of electrical remodeling that show loss of rate adaptation.1 2 However, our findings are consistent with those of Pandozi et al,28 who demonstrated ERP adaptation to rate after cardioversion of long-term AF in humans, despite the presence of electrical remodeling. Long-term DDD pacing produced a decrease in ERP dispersion, raising the possibility that this effect may play a part in the described prevention of AF paroxysms after dual-chamber pacemaker implantation.29

Potential Mechanisms for Electrical Remodeling and AF After Loss of AV Synchrony
Stretch-activated channels have recently been identified in the atrium, and they may play a role in the observed ERP lengthening.30 Long-term atrial stretch may lead to fibrosis and glycogen accumulation in atrial tissue; the electrical changes observed may be a manifestation of these structural derangements.24 25 31 A change in the expression and conformation of atrial connexins might also underlie the observed changes in electrophysiology.32

It is important to consider why the changes observed after long-term VVI pacing might be associated with AF. Indeed, an increase in atrial ERPs alone would be expected to prevent AF due to an overall lengthening of wavelength. Potential mechanisms could be considered under the categories of substrate and triggers.

Substrate
First, the increase in atrial size and conduction slowing may facilitate multiple wavelet reentry and increase the ability to sustain AF.1 3 5 6 7 26 Second, the nonuniform increase in refractoriness might increase the propensity for reentry by favoring the development of functional block.3 5 Finally, sinus node dysfunction may induce heterogeneity of atrial recovery of excitability, promoting fractionation of impulse propagation and the development of multiple reentrant circuits.6 33

Triggers
Atrial early after depolarizations occurring in association with atrial stretch and atrial ERP prolongation may result in a polymorphic atrial tachyarrhythmia, degenerating into AF.34 AF in humans could potentially develop through this mechanism in the setting of atrial dilatation and ERP prolongation. Loss of AV synchrony might also lead to AF through the genesis of atrial ectopy. Preliminary studies in animals have demonstrated atrial ectopy and tachyarrhythmias in association with increased atrial ERPs after atrial dilatation. These foci display a similar distribution to those observed in human focal AF (pulmonary vein ostia and crista terminalis).35

Limitations
Right heart catheterization to assess atrial pressures was not performed because of the risks of displacing recently implanted pacing leads. AF inducibility was not assessed due to the possibility of inducing sustained AF, which would require cardioversion in patients who were not anticoagulated. We attempted to control for potential ERP variations between and within patients by using archived images to standardize catheter positions. Patients also had permanently implanted atrial leads, which allowed noninvasive, programmed stimulation from a fiducial RA site. ERP changes occurring with this lead paralleled those observed with the temporary electrodes. Finally, an intrastudy variation in ERPs of <5% was observed at baseline.

Conclusions
Long-term loss of AV synchrony induced by VVI pacing is associated with reversible electrical remodeling of the atrium. This electrical remodeling is characterized by a nonuniform prolongation of atrial ERPs and an increase in PWD, suggesting slowing of atrial conduction and impairment of sinus pacemaker function. These phenomena are accompanied by biatrial enlargement and do not occur in patients paced synchronously in the DDD mode. This atrial electrical remodeling process suggests a possible mechanism for the increased incidence of AF occurring in patients undergoing long-term asynchronous VVI pacing.


*    Acknowledgments
 
Dr Paul Sparks was funded by The National Heart Foundation of Australia as a Postgraduate Medical Research Scholar.

Received April 9, 1999; revision received July 6, 1999; accepted July 13, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92:1954–1968.[Abstract/Free Full Text]

2. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91:1588–1595.[Abstract/Free Full Text]

3. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation. 1998;98:2202–2209.[Abstract/Free Full Text]

4. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 1996;94:1600–1606.[Abstract/Free Full Text]

5. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7:833–842.[Medline] [Order article via Infotrieve]

6. Elvan A, Wylie K, Zipes DP. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs: electrophysiological remodeling. Circulation. 1996;94:2953–2960.[Abstract/Free Full Text]

7. Zipes DP. Atrial fibrillation: a tachycardia-induced atrial cardiomyopathy. Circulation. 1997;95:562–564.[Free Full Text]

8. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation. 1997;96:1686–1695.[Abstract/Free Full Text]

9. Klein LS, Miles WM, Zipes DP. Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure and refractory period. Circulation. 1990;82:60–68.[Abstract/Free Full Text]

10. Calkins H, El-Atassi R, Leon A, Kalbfleisch S, Borganelli M, Langberg J, Morady F. Effect of the atrioventricular relationship on atrial refractoriness in humans. Pacing Clin Electrophysiol.. 1992;15:771–778.[Medline] [Order article via Infotrieve]

11. Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997;350:1210–1216.[Medline] [Order article via Infotrieve]

12. Connolly SJ. Canadian trial of physiologic pacing: late breaking clinical trials. Presented at the 71st Scientific Sessions of the American Heart Association, Dallas, Tex, November 8–11, 1998.

13. Nielsen JC, Andersen HR, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Heart failure and echocardiographic changes during long term follow-up of patients with sick sinus syndrome randomized to single chamber atrial pacing or ventricular pacing. Circulation. 1998;97:987–995.[Abstract/Free Full Text]

14. Sgarbossa EB, Pinski SL, Maloney JD, Simmons TW, Wilkoff BL, Castle LW, Trohman RG. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome: relevance of clinical characteristics and pacing modalities. Circulation. 1993;88:1045–1053.[Abstract/Free Full Text]

15. Loperfido F, Pennestri F, Digaetano A, Scabbia E, Santarelli P, Mongiardo R, Schiavoni G, Coppola E, Manzoli U. Assessment of left atrial dimension by cross-sectional echocardiography in patients with mitral valve disease. Br Heart J. 1983;50:570–578.[Abstract/Free Full Text]

16. Prystowsky EN, Jackman WM, Rinkenberger RL, Heger JJ, Zipes DP. Effect of autonomic blockade on ventricular refractoriness and atrioventricular nodal conduction in humans. Circ Res. 1981;49:511–518.[Free Full Text]

17. Bland M. An Introduction to Medical Statistics. 2nd ed. Oxford, England: Oxford University Press; 1995.

18. Kaseda S, Zipes DP. Contraction-excitation feedback in the atria: a cause of changes in refractoriness. J Am Coll Cardiol. 1988;11:1327–1336.[Abstract]

19. Sideris DA, Toumanidis ST, Tselepatiotis E, Kostopoulos K, Stringli T, Kitsiou T, Moulopoulos SD. Atrial pressure and experimental atrial fibrillation. Pacing Clin Electrophysiol. 1995;18:1679–1685.[Medline] [Order article via Infotrieve]

20. Power JM, Beacom GA, Alferness CA, Raman J, Farish SJ, Tonkin AM. Effects of left atrial dilatation on the endocardial atrial defibrillation threshold: a study in an ovine model of pacing-induced dilated cardiomyopathy. Pacing Clin Electrophysiol. 1998;21:1595–600.[Medline] [Order article via Infotrieve]

21. Power JM, Beacom GA, Alferness CA, Raman J, Wijffels M, Farish SJ, Burrell LM, Tonkin AM. Susceptibility to atrial fibrillation: a study in an ovine model of pacing-induced early heart failure. J Cardiovasc Electrophysiol. 1998;9:423–435.[Medline] [Order article via Infotrieve]

22. Tse HF, Lau CP, Ayers GM. Heterogeneous changes in electrophysiologic properties in the paroxysmal and chronically fibrillating human atrium. J Cardiovasc Electrophysiol. 1999;10:125–135.[Medline] [Order article via Infotrieve]

23. Chen YJ, Chen SA, Tai CT, Yu WC, Feng AN, Ding YA, Chang MS. Electrophysiologic characteristics of a dilated atrium in patients with paroxysmal atrial fibrillation and atrial flutter. J Interv Card Electrophysiol. 1998;2:181–186.[Medline] [Order article via Infotrieve]

24. Boyden PA, Hoffman BF. The effects on atrial electrophysiology and structure of surgically induced right atrial enlargement in dogs. Circ Res. 1981;49:1319–1331.[Abstract/Free Full Text]

25. Boyden PA, Tilley LP, Pham TD, Liu S, Fenoglio JJ, Wit AL. Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis. Am J Cardiol. 1982;49:1896–1908.[Medline] [Order article via Infotrieve]

26. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Power J, Allessie MA. Electrical remodelling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation. 1997;96:3710–3720.[Abstract/Free Full Text]

27. Antoniou A, Milionas D, Kanakakis J, Rokas S, Sideris DA. Contraction-excitation feedback in human atrial fibrillation. Clin Cardiol. 1997;20:473–476.[Medline] [Order article via Infotrieve]

28. Pandozi C, Bianconi L, Villani M, Gentilucci G, Castro A, Altamura G, Jesi A, Lamberti F, Ammirati F, Santini M. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation. 1998;98:2860–2865.[Abstract/Free Full Text]

29. Delfaut P, Saksena S, Prakash A, Krol RB. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol. 1998;32:1900–1908.[Abstract/Free Full Text]

30. Kiseleva I, Kamkin A, Pylaev A, Kondratjev D, Leiterer KP, Theres H, Wagner KD, Persson PB, Gunther J. Electrophysiological properties of mechanosensitive atrial fibroblasts from chronic infarcted rat heart. J Mol Cell Cardiol. 1998;30:1083–1093.[Medline] [Order article via Infotrieve]

31. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 1997;96:3157–3163.[Abstract/Free Full Text]

32. Elvan A, Huang X, Pressler ML, Zipes DP. Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs. Circulation. 1997;96:1675–1685.[Abstract/Free Full Text]

33. Friedman HS, Sinha B, Tun A, Pasha R, Sharafkaneh A, Bharadwaj A. Zones of atrial vulnerability: relations to basic cycle length. Circulation. 1996;94:1456–1464.[Abstract/Free Full Text]

34. Satoh T, Zipes DP. Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes? J Cardiovasc Electrophysiol. 1998;9:970–975.[Medline] [Order article via Infotrieve]

35. Haissaguerre M, Jais P, Shah DC, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med.. 1998;339:659–666.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
EuropaceHome page
S. P. Bhavnani, C. I. Coleman, C. M. White, C. A. Clyne, R. Yarlagadda, D. Guertin, and J. Kluger
Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy
Europace, July 1, 2008; 10(7): 854 - 859.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. C. Roberts-Thomson, I. H. Stevenson, P. M. Kistler, H. M. Haqqani, J. C. Goldblatt, P. Sanders, and J. M. Kalman
Anatomically Determined Functional Conduction Delay in the Posterior Left Atrium: Relationship to Structural Heart Disease
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 856 - 862.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
I. C. Van Gelder and M. E.W. Hemels
The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm
Europace, November 1, 2006; 8(11): 943 - 949.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. W. Israel
The role of pacing mode in the development of atrial fibrillation.
Europace, February 1, 2006; 8(2): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Swissa, S. Zhou, O. Paz, M. C. Fishbein, L. S. Chen, and P.-S. Chen
Canine model of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1851 - H1857.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H.-R. Neuberger, U. Schotten, S. Verheule, S. Eijsbouts, Y. Blaauw, A. van Hunnik, and M. Allessie
Development of a Substrate of Atrial Fibrillation During Chronic Atrioventricular Block in the Goat
Circulation, January 4, 2005; 111(1): 30 - 37.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sanders, P. M. Kistler, J. B. Morton, S. J. Spence, and J. M. Kalman
Remodeling of Sinus Node Function in Patients With Congestive Heart Failure: Reduction in Sinus Node Reserve
Circulation, August 24, 2004; 110(8): 897 - 903.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. M. Kistler, P. Sanders, S. P. Fynn, I. H. Stevenson, S. J. Spence, J. K. Vohra, P. B. Sparks, and J. M. Kalman
Electrophysiologic and electroanatomic changes in the human atrium associated with age
J. Am. Coll. Cardiol., July 7, 2004; 44(1): 109 - 116.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L Kristensen, J C Nielsen, P T Mortensen, O L Pedersen, A K Pedersen, and H R Andersen
Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome
Heart, June 1, 2004; 90(6): 661 - 666.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sanders, J. B. Morton, P. M. Kistler, S. J. Spence, N. C. Davidson, A. Hussin, J. K. Vohra, P. B. Sparks, and J. M. Kalman
Electrophysiological and Electroanatomic Characterization of the Atria in Sinus Node Disease: Evidence of Diffuse Atrial Remodeling
Circulation, March 30, 2004; 109(12): 1514 - 1522.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sanders, J. B. Morton, N. C. Davidson, S. J. Spence, J. K. Vohra, P. B. Sparks, and J. M. Kalman
Electrical Remodeling of the Atria in Congestive Heart Failure: Electrophysiological and Electroanatomic Mapping in Humans
Circulation, September 23, 2003; 108(12): 1461 - 1468.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Hocini, P. Sanders, I. Deisenhofer, P. Jais, L.-F. Hsu, C. Scavee, R. Weerasoriya, F. Raybaud, L. Macle, D. C. Shah, et al.
Reverse Remodeling of Sinus Node Function After Catheter Ablation of Atrial Fibrillation in Patients With Prolonged Sinus Pauses
Circulation, September 9, 2003; 108(10): 1172 - 1175.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. O. Sweeney, A. S. Hellkamp, K. A. Ellenbogen, A. J. Greenspon, R. A. Freedman, K. L. Lee, and G. A. Lamas
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
Circulation, June 17, 2003; 107(23): 2932 - 2937.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Verheule, E. Wilson, T. Everett IV, S. Shanbhag, C. Golden, and J. Olgin
Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation
Circulation, May 27, 2003; 107(20): 2615 - 2622.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. B. Morton, P. Sanders, J. K. Vohra, P. B. Sparks, J. G. Morgan, S. J. Spence, L. E. Grigg, and J. M. Kalman
Effect of Chronic Right Atrial Stretch on Atrial Electrical Remodeling in Patients With an Atrial Septal Defect
Circulation, April 8, 2003; 107(13): 1775 - 1782.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
W. LI, H. B XIAO, M. Y HENEIN, J. SOMERVILLE, and D. G GIBSON
Progressive ECG changes before the onset of atrial flutter in adult congenital heart disease patients
Heart, June 1, 2001; 85(6): 703 - 703.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sparks, P. B.
Right arrow Articles by Kalman, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sparks, P. B.
Right arrow Articles by Kalman, J. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation
*Pacemakers and Implantable Defibrillators
Related Collections
Right arrow Remodeling
Right arrow Pacemaker
Right arrow Arrhythmias, clinical electrophysiology, drugs